W2O Acquires Symplur to Innovate, Scale and Increase Accessibility to Its Proprietary Healthcare Data and Insights Platform
Summary
Through a collaboration with the California Life Sciences Association, W2O and Symplur are already utilizing the platform in conjunction with W2O’s proprietary data and technology stack to track COVID-19-specific conversations and trends across the healthcare ecosystem. “Particularly in these challenging, uncertain times reverberating across global communities and economies, healthcare companies are looking to track essential information in an urgent and immediate manner utilizing data and analytics to discern insights for decision-making,” said W2O Founder and CEO Jim Weiss. To that end, we continue to look for innovative companies and technology that can enrich our offering in these critical areas.” Headquartered in Pasadena, Calif., Symplur’s unmatched social media analytics platform tracks how physicians and other healthcare stakeholders produce and consume medical information online, which increasingly appears in free, open-access environments such as Twitter. Symplur’s additional solutions-oriented capabilities include influencer analyses, which utilize proprietary recursive algorithms to accurately identify the true influencers in any given healthcare topic; stakeholder segmentation, which identifies and categorizes the people behind the conversations; classification, which combines human curation and automated processes to organize, structure and appropriately categorize raw social data; and engagement analyses, which measure levels of engagement to determine what is resonating and driving conversations. The Company applies proprietary analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business and organizational results.